Responses
Regular and Young Investigator Award Abstracts
Immuno-Engineering
1224 Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.